Heavily pre-treated FLT3-mutated AML population may benefit from novel triplet regimen

Presented By

Dr Musa Yilmaz, MD Anderson Cancer Center, TX, USA

Conference

ASH 2021

4 February, 2022 11:46

ASH 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ASH 2021

4 January, 2022 08:00

Presented By

Dr Abhishek Maiti, University of Texas MD Anderson Cancer Centre, USA

Trial

Phase 2

Conference

EHA 2020

9 September, 2020 13:18

Presented By

Dr Xiaowen Tang; Dr James Foran

Trial

Phase 2, ECOG-ACRIN E2906

Conference

ASH 2019

5 March, 2020 13:16